decisionhealth Newsletters, Coder Pink Sheets - 2005 Issue 4 (April)
CMS proposes to remove your Medicare drug-billing worries
Subscribe or sign in to view the full article.
Article Overview
This article covers a CMS proposal affecting Medicare Part B drug acquisition and billing for outpatient drugs and biologicals. It is relevant to physicians, billing staff, and specialty practices that administer drugs in-office, especially pain management and other specialties that may be phased into the program. The discussion focuses on the proposed competitive acquisition approach, implementation timing, participation structure, and the opportunity to comment on the rule.
Why This Topic Matters
The proposal could change operational and billing workflows for practices that furnish Medicare drugs in the office setting, so understanding the framework and implementation timeline is important for reimbursement planning.
What You Will Learn
- What CMS is proposing for Medicare outpatient drug acquisition and billing
- How the competitive acquisition program is expected to be structured at a high level
- Which types of practices and specialties may be affected first
- How the rulemaking comment process fits into the proposal timeline
Who Should Read This
- Physicians
- Billing and coding professionals
- Practice managers
- Pain management clinics
- Other outpatient specialty practices
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com